Center Publications

Tran, Hao Q, et al. “‘Western Diet’-Induced Adipose Inflammation Requires a Complex Gut Microbiota”. 2020. Cellular and Molecular Gastroenterology and Hepatology, vol. 9, no. 2, 2020, pp. 313–333.

Khosravi-Maharlooei, Mohsen, et al. “Rapid Thymectomy of NSG Mice to Analyze the Role of Native and Grafted Thymi in Humanized Mice”. 2020. European Journal of Immunology, vol. 50, no. 1, 2020, pp. 138–141.

Kuznetsova, Tatyana, et al. “Transcriptional and Epigenetic Regulation of Macrophages in Atherosclerosis”. 2020. Nature Reviews. Cardiology, vol. 17, no. 4, 2020, pp. 216–228.

Gingerich, Morgan A, et al. “Clarifying the Function of Genes at the Chromosome 16p13 Locus in Type 1 Diabetes: CLEC16A and DEXI”. 2020. Genes and Immunity, vol. 21, no. 2, 2020, pp. 79–82.

Prahalad, Priya, et al. “CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time”. 2020. Diabetes Care, vol. 43, no. 1, 2020, pp. e3-e4.

Tavares, Mariana Rosolen, et al. “Modulation of Hypothalamic S6K1 and S6K2 Alters Feeding Behavior and Systemic Glucose Metabolism”. 2020. The Journal of Endocrinology, vol. 244, no. 1, 2020, pp. 71–82.

Chiu, Chien-Hung, et al. “Morphomic Factors Associated With Complete Response to Neoadjuvant Therapy in Esophageal Carcinoma”. 2020. The Annals of Thoracic Surgery, vol. 109, no. 1, 2020, pp. 241–248.

Rios-Arce, Naiomy D, et al. “Loss of Interleukin-10 Exacerbates Early Type-1 Diabetes-Induced Bone Loss”. 2020. Journal of Cellular Physiology, vol. 235, no. 3, 2020, pp. 2350–2365.

Liu, Li, et al. “Glycyrrhizin Protects IGFBP-3 Knockout Mice from Retinal Damage”. 2020. Cytokine, vol. 125, 2020, p. 154856.

Berglund, Erik, et al. “Safety and Pharmacodynamics of Anti-CD2 Monoclonal Antibody Treatment in Cynomolgus Macaques - an Experimental Study”. 2020. Transplant International : Official Journal of the European Society for Organ Transplantation, vol. 33, no. 1, 2020, pp. 98–107.

Weir, Gordon C. “Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes”. 2020. Diabetes, vol. 69, no. 3, 2020, pp. 273–278.

Alkhouri, Naim, et al. “GS-0976 (Firsocostat): An Investigational Liver-Directed Acetyl-CoA Carboxylase (ACC) Inhibitor for the Treatment of Non-Alcoholic Steatohepatitis (NASH)”. 2020. Expert Opinion on Investigational Drugs, vol. 29, no. 2, 2020, pp. 135–141.